|
QuintilesIMS Real-World Insights Bibliography
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. |
| Author(s): Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. |
| Affiliations(s): 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
2Centre for Observational Research, Amgen Ltd, Uxbridge, UK.
3IMS Health Sweden, Stockholm, Sweden.
|
| Publication(s): Clinical Epidemiology |
| Document Type(s): Article |
| Countries: Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Oncology
2016 |
|
L:
A: |
English
Literature Review |
|
 |
| |
| |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. |
| Author(s): Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 |
| Affiliations(s): 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium |
| Publication(s): 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
| Document Type(s): Abstract |
| Countries: Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK |
C:
Y: |
Cardiovascular disease
2016 |
|
L:
A: |
English
|
|
|
| |
| |
| Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study. |
| Author(s): Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. |
| Affiliations(s): 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com.
2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium.
3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany.
4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom.
6Gastroenterology Practice, Minden, Germany.
7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.
8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom.
10IMS Health, Real World Evidence Solutions, Spain.
11Merck & Co., Inc., Kenilworth, NJ, United States
|
| Publication(s):
Dig Liver Dis. 2016 Jun;48(6):601-7. |
| Document Type(s): Article |
| Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK |
C:
Y: |
Gastrointestinal disorders
2016 |
|
L:
A: |
English
Burden of illness, Patient questionnaire, Survey research |
|
|
| |
| |
| Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study |
| Author(s): Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. |
| Affiliations(s): 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be.
2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany.
4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK.
6Gastroenterology Practice, Minden, Germany.
7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece.
8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy.
9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.
10IMS Health, Real World Evidence Solutions, Barcelona, Spain.
11Merck & Co., Inc., Rahway, NJ, United States.
|
| Publication(s): Dig Liver Dis. 2016 Jun;48(6):592-600 |
| Document Type(s): Article |
| Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK |
C:
Y: |
Gastrointestinal disorders
2016 |
|
L:
A: |
English
Burden of illness, Patient questionnaire |
|
|
| |
| |
| ESTIMATION OF DIRECT MEDICAL COSTS ASSOCIATED WITH TREATMENT OF METASTATIC MELANOMA IN SWITZERLAND |
| Author(s): Christoffersen P1, Khan N1, Lucas J1, Christodoulopoulou A2, Del Ponte A2, Gutzwiller F2 |
| Affiliations(s): 1IMS Health, Basel, Switzerland, 2Amgen Switzerland AG, Zug, Switzerland |
| Publication(s): ISPOR 18th Annual European Congress
Milan, Italy
November, 2015 |
| Document Type(s): Poster |
| Countries: Switzerland |
C:
Y: |
Oncology
2015 |
|
L:
A: |
English
|
|
|
| |
| |
| Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland |
| Author(s): Samyshkin Y1, Schlunegger M2, Haefliger S3, Ledderhose S3, Radford M1 |
| Affiliations(s): 1 IMS Health, HEOR, London, UK 2 Marketing Specialty Care 3 Takeda Pharma AG, Pfäffikon, Switzerland |
| Publication(s): International Journal of COPD 8:79-87 |
| Document Type(s): Article |
| Countries: Switzerland |
C:
Y: |
Respiratory disease
2013 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Treatment cost of acute coronary syndrome with ticagrelor compared to clopidogrel in Switzerland. |
| Author(s): Gasche D1, Ulle T2, Meier B3, Greiner RA1 |
| Affiliations(s): 1 IMS Health, Munich, Germany 2 AstraZeneca AG, Zug, Switzerland 3 Department of Cardiology, Bern University Hospital, Bern, Switzerland |
| Publication(s): Gemeinsamen Jahrestagung der Schweizerischen Gesellschaften für Kardiologie und der Schweizerischen Gesellschaft für Herz- und Thorakale Gefässchirurgie - in press, 2013. |
| Document Type(s): Poster |
| Countries: Switzerland |
C:
Y: |
Cardiovascular disease
2013 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
| Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden. |
| Author(s): Valentine WJ1, Aagren M2, Haglund M3-4, Ericsson A3, Gschwend MH5 |
| Affiliations(s): 1Ossian Health Economics and Communication, Basel, Switzerland, 2Novo Nordisk Inc., Princeton, NJ, USA, 3Novo Nordisk Scandinavia AB, Malmo, Sweden, 4NeuroSearch A/S, Ballerup, Denmark and 5IMS Health, Basel, Switzerland |
| Publication(s): Scandinavian journal of public health |
| Document Type(s): Manuscript in preparation |
| Countries: Switzerland |
| Click here for the abstract |
C:
Y: |
Diabetes
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Cost-effectiveness of Roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland |
| Author(s): Samyshkin Y1, Radford M1, Schlunegger M2, Gooss A2
|
| Affiliations(s): 1IMS Health, London, UK, 2Nycomed Pharma AG, Dübendorf, Switzerland |
| Publication(s): ISPOR 14th Annual European Conference, 5-8 November 2011, Madrid, Spain |
| Document Type(s): Poster |
| Countries: Switzerland |
| Click here for the abstract |
C:
Y: |
Respiratory disease
2011 |
|
L:
A: |
English
Cost effectiveness |
|
|
| |
| |
| Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. |
| Author(s): Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7,
Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10,
Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 |
| Affiliations(s): 1
Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2
CIBER of
Epidemiology and Public Health, Madrid, Spain; 3
Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4
Department of Epidemiology, Johns Hopkins Bloomberg School
of Public Health, Baltimore, MD 21205, USA; 5
Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6
Welch Center for
Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7
Department of Cardiovascular Epidemiology and
Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8
Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN,
UK; 9
Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003
Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium |
| Publication(s): Eur Heart J. 2011 Sep;32(17):2143-52 |
| Document Type(s): Article |
| Countries: Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease
2011 |
|
L:
A: |
English
Observational study, Prospective study |
|
|
| |
| |
 1 of 2 
|
|
